Insulin glargine and Tolterodine Extended-Release Capsules
Determining the interaction of Insulin glargine and Tolterodine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin Glargine
Generic Name: tolterodine
Brand name: Detrol, Detrol LA
Synonyms: Tolterodine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine-Tolterodine Tablets
- Insulin glargine-Tolterodine Tartrate
- Insulin glargine-Tolterodine Tartrate Capsules
- Insulin glargine-Tolterodine Tartrate Tablets
- Insulin glargine-Tolvaptan
- Insulin glargine-Tolvaptan (Jynarque/Jinarc)
- Tolterodine Extended-Release Capsules-Insulin Glargine (U-100) Cartridge Systems and Pens
- Tolterodine Extended-Release Capsules-Insulin Glargine (U-100) Vials
- Tolterodine Extended-Release Capsules-Insulin Glargine (U-300) Pens
- Tolterodine Extended-Release Capsules-Insulin glargine and lixisenatide
- Tolterodine Extended-Release Capsules-Insulin glargine and lixisenatide Subcutaneous
- Tolterodine Extended-Release Capsules-Insulin glargine, recombinant Subcutaneous